ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 720065 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 720065; 2) Community: the network communities that were significantly associated with the response to NSC 720065; 3) Molecule: the relationships between components within communities and NSC 720065; 4) MDR: the compounds that were significantly associated with the NSC 720065.

NSC Compound Enrichment Correlation
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.012942183459279 0.28639593
NSC 735472 (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol 0.012942183459279 0.076461042
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.012942183459279 0.53172287
NSC 752761 Null 0.012942183459279 0.095262993
NSC 755880 Mitomycin (USAN) 0.012942183459279 0.21835208
NSC 756375 GW811761X 0.012942183459279 -0.0016352232
NSC 76455 Antibiotic from Streptomyces luteogriseus 0.012942183459279 0.14502172
NSC 19441 FDA 0283 0.0133012546828912 0.13241159
NSC 25846 Null 0.0133012546828912 0.26547758
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0133012546828912 0.20418126
Total:85  Current:30    [First] [Prev] [Next] [Last]